1. AB0076 Jak inhibitor baricitinib modulates human innate and adaptive immune system. (12th June 2018) Authors: Kubo, S.; Nakayamada, S.; Ma, X.; Lee, S.; Yamagata, K.; Nakano, K.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Tamaki, Y.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0415 A New Prognostic Factor to Sustain Remission for 2 Years after Adalimumab Discontinuation & the Clinical Outcomes in RA Patients: Honor Study 2-Years Results. (10th June 2014) Authors: Tanaka, Y.; Hirata, S.; Kubo, S.; Fukuyo, S.; Hanami, K.; Sawamukai, N.; Nakano, K.; Nakayamada, S.; Yamaoka, K.; Saito, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0546 Clinical and functional remission based on newly defined ACR/EULAR remission criteria achieved with tocilizumab in patients with rheumatoid arthritis. (23rd January 2014) Authors: Hanami, K.; Saito, K.; Tasaka, H.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study. (23rd January 2014) Authors: Tanaka, Y.; Takeuchi, T.; Amano, K.; Sato, E.; Nawata, M.; Nagasawa, H.; Hoshi, D.; Saito, K.; Fukuyo, S.; Hanami, K.; Kameda, H.; Kurasawa, T.; Kaneko, Y.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0066 Behavior of the multi-biomarker disease activity (vectra da algorithm) score and components in patients with rheumatoid arthritis treated with tocilizumab. (23rd January 2014) Authors: Hanami, K.; Hirata, S.; Tasaka, H.; Li, W.; Bolce, R.; Sasso, E. H.; Defranoux, N. A.; Yamaoka, K.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0097 Baseline Serum 14-3-3 ETA Independently Predicts Clinically Important Improvements in HAQ-DI in Patients with Rheumatoid Arthritis Treated with Tocilizumab. (15th July 2016) Authors: Hirata, S.; Hanami, K.; Marotta, A.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0102 SERUM TNFΑ LEVELS AT 24 HOURS AFTER FIRST ADMINISTRATION OF CERTOLIZUMAB PEGOL PREDICT EFFECTIVENESS AT WEEK 12 IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM TSUBAME STUDY (UMIN ID:0002381). (2nd June 2020) Authors: Miyazaki, Y.; Nakano, K.; Nakayamada, S.; Kubo, S.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Yamaguchi, A.; Kawabe, A.; Kazuyoshi, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0170 The Comparative Effectiveness of Five Biologics as Second-Line Use for Patients with Rheumatoid Arthritis in Daily Clinical Practice. (9th June 2015) Authors: Saito, K.; Nakano, K.; Nakayamada, S.; Hirata, S.; Kubo, S.; Fukuyo, S.; Miyagawa, I.; Sawamukai, N.; Hanami, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0190 CDAI is a predictor of physical function and bone destruction at week 52 in RA patients. (23rd January 2014) Authors: Hanami, K.; Saito, K.; Tasaka, H.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA). (23rd January 2014) Authors: Saito, K.; Hanami, K.; Hirata, S.; Kubo, S.; Nawata, M.; Yamaoka, K.; Nakayamada, S.; Nakano, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗